Clonmel-based Shorla Oncology to increase revenues significantly
The 2025 EY Entrepreneur of The Year programme is open for nominations today. At the launch (l-r): EY Entrepreneur of The Year director Eimear McCrann, EY Entrepreneurs of the Year 2024 Orlaith Ryan and Sharon Cunningham of Shorla Oncology, and award's lead partner Roger Wallace. Picture: Naoise Culhane
The CEO of Shorla Oncology said on Thursday that the business expects to increase revenues significantly in 2025.
Ms Sharon Cunningham was commenting on new accounts for the Clonmel-headquartered Shorla Pharma Ltd which show that the group recorded a pre-tax loss of €8.07m in 2023 as the business continued in its development phase.
